CRGD conjugated mPEG-PLGA-PLL nanoparticles for SGC-7901 gastric cancer cells-targeted delivery of fluorouracil

Journal of Nanoscience and Nanotechnology

Volumn 12, Issue 6, 2012, Pages 4467-4471

  Liu, Peifeng ^a,b   Wang, Hongbin ^c   Wang, Qi ^a,b,d   Sun, Ying ^a,b   Shen, Ming ^a,b   Zhu, Mingjie ^a,b   Wan, Zhiyong ^e   Duan, Yourong ^a,b  

^a SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

^b SHANGHAI CANCER INSTITUTE   (China)

^c SHANGHAI PUNAN HOSPITAL   (China)

^d SICHUAN UNIVERSITY   (China)

^e SHANGHAI JIAO TONG UNIVERSITY   (China)

Author keywords

Delivery Carrier; Gastric Cancer; Nanoparticles; Tumor Target

Indexed keywords

AVERAGE PARTICLE SIZE; CONFOCAL LASER SCANNING MICROSCOPE; DELIVERY CARRIER; FLOW-CYTOMETER; FLUORESCENCE INTENSITIES; FLUOROURACIL; GASTRIC CANCER CELLS; GASTRIC CANCERS; IN-VITRO; L-LYSINE;

AMINO ACIDS; CELLS; CYTOTOXICITY; DISEASES; NANOPARTICLES; ORGANIC POLYMERS; POLYETHYLENE GLYCOLS; RUBIDIUM; ZETA POTENTIAL;

MOTION PICTURE EXPERTS GROUP STANDARDS;

ANTINEOPLASTIC AGENT; CYCLIC ARGININE GLYCINE ASPARTIC ACID PEPTIDE; CYCLIC ARGININE-GLYCINE-ASPARTIC ACID PEPTIDE; CYCLOPEPTIDE; DRUG DERIVATIVE; FLUOROURACIL; MACROGOL DERIVATIVE; MONOMETHOXY (POLYETHYLENE GLYCOL) POLY(LACTIDE CO GLYCOLIDE) POLY(LYSINE); MONOMETHOXY (POLYETHYLENE GLYCOL)-POLY(LACTIDE-CO-GLYCOLIDE)-POLY(LYSINE); NANOCAPSULE; POLYESTER; POLYLYSINE;

ARTICLE; CHEMISTRY; DIFFUSION; HUMAN; MATERIALS TESTING; METHODOLOGY; MOLECULARLY TARGETED THERAPY; PATHOLOGY; STOMACH TUMOR; TREATMENT OUTCOME; TUMOR CELL LINE;

ANTINEOPLASTIC AGENTS; CELL LINE, TUMOR; DIFFUSION; FLUOROURACIL; HUMANS; MATERIALS TESTING; MOLECULAR TARGETED THERAPY; NANOCAPSULES; PEPTIDES, CYCLIC; POLYESTERS; POLYETHYLENE GLYCOLS; POLYLYSINE; STOMACH NEOPLASMS; TREATMENT OUTCOME;

EID: 84863883947     PISSN: 15334880     EISSN: 15334899     Source Type: Journal    
DOI: 10.1166/jnn.2012.6213     Document Type: Article

References (32)

1. R. R. Love, H. Leventhal, D. V. Easterling, and D. R. Nerenz, Cancer 3, 604, (1989).
2. N. Carelle, E. Piotto, A. Bellanger, J. Germanaud, A. Thuillier, and D. Khayat, Cancer 95, 155 (2002).
3. V. H. Phan, M. M. Moore, A. J. McLachlan, M. Piquette-Miller, H. M. Xu, and S. J. Clarke, Expert Opin. Drug Metab. Toxicol. 5, 243 (2009).
4. J. J. Monsuez, J. C. Charniot, N. Vignat, and J. Y. Artigou, Int. J. Cardiol. 144, 3 (2010).
5. K. Van der Speeten, O. A. Stuart, H. Mahteme, and P. H. Sugarbaker, Cancer Chemother. Pharmacol. 63, 799 (2009).
6. G. Milano and A. L. Chamorey, Chronobiol. Int. 19, 177 (2002).
7. N. Rapoport, Z. G. Gao, and A. Kennedy, J. Natl. Cancer Inst. 99, 1095 (2007).
8. K. Cho, X. Wang, S. M. Nie, Z. Chen, and D. M. Shin, Clin. Cancer Res. 14, 1310 (2008).
9. J. Fu, D. X. Wang, T. Wang, W. J. Yang, Y. Deng, H. Wang, S. G. Jin, and N. Y. He, J. Biomed. Nanotechnol. 6, 725 (2010).
10. G. Devanand Venkatasubbu, S. Ramasamy, V. Ramakrishnan, and J. Kumar, J. Biomed. Nanotechnol. 7, 759 (2011).
11. J. Wang, H. N. Tan, A. H. Yu, P. X. Ling, H. X. Lou, G. X. Zhai, and J. Wu, J. Biomed. Nanotechnol. 7, 696 (2011).
12. W. J. Yang, J. Fu, T. Wang, and N. Y. He, J. Biomed. Nanotechnol. 5, 591 (2009).
13. N. Sanoj Rejinold, M. Muthunarayanan, K. P. Chennazhi, S. V. Nair, and R. Jayakumar, J. Biomed. Nanotechnol. 7, 521 (2011).
14. M. Rafat, C. A. Cléroux, W. G. Fong, A. N. Baker, B. C. Leonard, M. D. OConnor, and C. Tsilfidis, Biomaterials 31, 3414 (2010).
15. R. Bakhshi, Z. Ahmad, M. Soric, E. Stride, and M. Edirisinghe, J. Biomed. Nanotechnol. 7, 782 (2011).
16. S. Rai, R. Paliwal, and S. P. Vyas, J. Biomed. Nanotechnol. 7, 121 (2011).
17. H. J. Cho, Y. L. Yoon, H. Koo, S. H. Ko, J. S. Shim, J. H. Lee, K. Kim, I. C. Kwon, and D. D. Kim, Biomaterials 32, 7181 (2011).
18. M. Foldvari, J. Biomed. Nanotechnol. 6, 543 (2010).
19. C. X. Guo, L. Zeng, S. Q. Liu, Q. Chen, Z. F. Dai, and X. Y. Wu, J. Nanosci. Nanotechnol. 12, 245 (2012).
20. K. K. Singh and P. Pople, J. Biomed. Nanotechnol. 7, 40 (2011).
21. P. Singh, A. Gupta, A. Jaiswal, A. Dube, S. Mishra, and M. K. Chaurasia, J. Biomed. Nanotechnol. 7, 50 (2011).
22. G. Sarfati, T. Dvir, M. Elkabets, R. N. Apte, and S. Cohen, Biomaterials 32, 152 (2011).
23. P. F. Liu, H. Z. Wang Y. G. Li, and Y. R. Duan, J. Macromol. Sci. A 46, 1024 (2009).
24. A. Taheri, R. Dinarvand, F. Atyabi, F. Nouri, F. Ahadi, M. H. Ghahremani, S. N. Ostad, A. T. Borougeni, and P. Mansoori, J. Biomed. Nanotechnol. 7, 743 (2011).
25. P. F. Liu, X. L. Qi, Y. Sun, H. Z. Wang, and Y. R. Duan, J. Nanosci. Nanotechnol. 11, 10760 (2011).
26. P. F. Liu, H. Yu, Y. Sun, M. J. Zhu, and Y. R. Duan, Biomaterials 33, 4403 (2012).
27. P. F. Liu, Z. H. Li, M. J. Zhu, Y. G. Li, H. Z. Wang, and Y. R. Duan, J. Mater. Sci-Mater. M 21, 551 (2010).
28. P. Dandekar, R. Jain, C. Kumar, S. Subramanian, G. Samuel, M. Venkatesh, and V. Patravale, J. Biomed. Nanotechnol. 5, 445 (2009).
29. H. Y. Huang, W. T. Kuo, M. J. Chou, and Y. Y. Huang, J. Biomed. Mater. Res. A 97, 330 (2011).
30. S. B. Zhou, X. M. Deng, and X. H. Li, J. Control. Rel. 75, 27 (2001).
31. M. Singh, S. Manikandan, and A. K. Kumaragure, J. Nanosci. Nanotechnol. 1, 1 (2011).
32. Z. H. Xu, L. L. Chen, W. W. Gu, Y. Gao, L. P. Lin, Z. W. Zhang, Y. Xi, and Y. P. Li, Biomaterials 30, 226 (2009).